About this Video

• Video Title: This Is Why You Can't Get ADHD Treatment
• Channel: Benn Jordan
• Speakers: Benn Jordan
• Duration: 20:15

Introduction

This video explores the difficulties in obtaining ADHD treatment, particularly the medication shortage in the United States. The speaker, Benn Jordan, shares his personal experience navigating the system after receiving an ADHD diagnosis and discusses the underlying causes and consequences of the shortage, including the involvement of the DEA and the rise of the black market for ADHD medications.

Key Takeaways

• ADHD Diagnosis and Treatment Challenges: The speaker details his personal struggles obtaining ADHD medication due to shortages. He emphasizes the difficulties faced by many Americans in accessing necessary treatment.
• The Dangers of Untreated ADHD: The video presents numerous studies highlighting the increased risks associated with untreated ADHD, including higher mortality rates, substance abuse, mental health issues, and car accidents.
• The Role of the DEA: The DEA's role in limiting amphetamine production is examined, with the speaker questioning the rationale behind these restrictions and suggesting a lack of evidence supporting the claim of widespread abuse.
• The Black Market for ADHD Medication: Due to shortages, the video shows the significant rise of illegal ADHD medication sales on the black market, posing serious health risks to consumers.
• Alternative Treatments: The video briefly mentions non-stimulant medications and neurofeedback therapy as alternative treatment options, acknowledging their limitations compared to stimulants.

The video attributes the difficulty in obtaining ADHD medication to a confluence of factors:

1. DEA Quotas: The DEA imposed limits on the amount of amphetamines that drug companies can purchase to manufacture medication. The video questions the evidence supporting this decision, suggesting it may not be proportional to the actual level of abuse and disproportionately affects those needing legitimate treatment.

2. Drug Shortages: The DEA's quotas, combined with other factors not fully explained in the video, have resulted in significant drug shortages. Manufacturers haven't produced the full amount permitted, creating a shortfall of billions of doses. Drug companies are not required to explain reasons for shortages, hindering transparency.

3. Increased Demand & Black Market: The increased difficulty in obtaining medication legally has led to a substantial rise in demand on the black market, where counterfeit and potentially dangerous medications are sold. This further exacerbates the problem and introduces significant health risks.